Autifony Therapeutics
Autifony Therapeutics is a biotechnology company developing medicines to treat hearing disorders such as hearing loss and tinnitus.
Total raised
€10M
€10,008,000
Funding rounds
2
Investors
0
distinct backers
Active since
2011-07
latest 2014-05
Funding by year
EUR raised per yearSignals
Medium confidenceRaise-next likelihood10
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Down/flat last round
Exit likelihood13
base rate 12% (2+ rounds)
- ▲ 19y since founding
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2014-06-01 | Other | €3.1M | — | View deal → |
| 2011-08-01 | Other | €7.0M | — | View deal → |